Keywords: Allergan, Molecular Partners, DARPin products, Ophthalmic diseases, Partnership

Allergan and Molecular expand partnership to develop novel products for eye diseases

Article | 22 August 2012

USA-based Allergan, Inc. (NYSE: AGN) and Switzerland’s Molecular Partners AG have significantly expanded their existing relationship signed last ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Molecular Partners

Go to company listing